MKI67 and neoplasm: The recurrent tumor acquired CCND3 amplification on a subsequent resection, followed by the acquisition of CDKN2A/B loss, mismatch repair deficiency, and alkylator-induced somatic hypermutation, which was identified in a liver metastasis that had a Ki67 of 50% [32].